Related Experiment Video
Updated: May 12, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Sustained and diffuse 131I avid bone metastases with low thyroglobulin levels in a patient with papillary thyroid
Chun-Lei Zhao1, Zhong-Ling Qiu, Li-Bo Chen
1Department of Nuclear Medicine, Hangzhou First People's Hospital, Hangzhou Cancer Hospital, Hangzhou, China.
Abstract:
A 63-year-old man with papillary thyroid carcinoma (PTC) and bone metastases was treated with 131I residual thyroid ablation (RTA) and 2 repeated post-ablation 131I therapies after total thyroidectomy. 131I whole-body scans (WBS) demonstrated sustained and diffuse 131I avid bone metastases, accompanied by persistent very low thyroglobulin (Tg) levels and negative antithyroglobulin antibody (TgAb) in post-ablation 131I therapies in hypothyroid state after levothyroxine withdrawal. The spread of bone metastases were found on the last therapeutical 131I WBS. The benefit of 131I therapy after levothyroxine withdrawal should be weighed even if the metastases are 131I avid in poorly differentiated thyroid carcinoma.
Related Concept Videos
Graves Disease II: Pathophysiology
Hyperthyroidism II: Pathophysiology
Goiter
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction
Graves' Disease I: Introduction

